These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26220383)

  • 1. GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
    Jang HW; Kim SW; Cho YJ; Heo K; Lee BI; Lee SK; Jang IJ; Lee MG; Kim WJ; Lee JH
    Epilepsy Res; 2015 Sep; 115():88-94. PubMed ID: 26220383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive markers for carbamazepine and lamotrigine-induced maculopapular exanthema in Han Chinese.
    Li LJ; Hu FY; Wu XT; An DM; Yan B; Zhou D
    Epilepsy Res; 2013 Sep; 106(1-2):296-300. PubMed ID: 23830818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population.
    Moon J; Park HK; Chu K; Sunwoo JS; Byun JI; Lim JA; Kim TJ; Shin JW; Lee ST; Jung KH; Jung KY; Jeon D; Kim DW; Yu KS; Jang IJ; Kang HR; Park HW; Lee SK
    Epilepsia; 2015 Oct; 56(10):e161-7. PubMed ID: 26282450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population.
    An DM; Wu XT; Hu FY; Yan B; Stefan H; Zhou D
    Epilepsy Res; 2010 Dec; 92(2-3):226-30. PubMed ID: 21071176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.
    Shi YW; Min FL; Liu XR; Zan LX; Gao MM; Yu MJ; Liao WP
    Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):42-6. PubMed ID: 21306565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of long-term lamotrigine in epilepsy.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis.
    Deng Y; Li S; Zhang L; Jin H; Zou X
    Seizure; 2018 Aug; 60():163-171. PubMed ID: 30015149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.
    Man CB; Kwan P; Baum L; Yu E; Lau KM; Cheng AS; Ng MH
    Epilepsia; 2007 May; 48(5):1015-8. PubMed ID: 17509004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
    Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
    Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Lamotrigine-associated rash.
    Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR
    Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy.
    Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP
    Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of lamotrigine.
    Richens A
    Epilepsia; 1994; 35 Suppl 5():S37-40. PubMed ID: 8039469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients.
    Zhou Y; Wang X; Li H; Zhang J; Chen Z; Xie W; Zhang J; Li J; Zhou L; Huang M
    Drug Metab Pharmacokinet; 2015 Aug; 30(4):282-7. PubMed ID: 26213157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
    Gélisse P; Crespel A
    Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine-induced rash--worth a rechallenge.
    P-Codrea Tigaran S; Sidenius P; Dam M
    Acta Neurol Scand; 2005 Mar; 111(3):191-4. PubMed ID: 15736314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.
    Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
    Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in patients with newly diagnosed epilepsy predicts lamotrigine-induced rash: a short-term observational study.
    Park SP
    Epilepsy Behav; 2013 Jul; 28(1):88-90. PubMed ID: 23673289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis.
    Wang XQ; Xiong J; Xu WH; Yu SY; Huang XS; Zhang JT; Tian CL; Huang DH; Jia WQ; Lang SY
    Seizure; 2015 Feb; 25():52-61. PubMed ID: 25645637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine hypersensitivity in childhood epilepsy.
    Iannetti P; Raucci U; Zuccaro P; Pacifici R
    Epilepsia; 1998 May; 39(5):502-7. PubMed ID: 9596202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between non-bullous skin reactions from lamotrigine and heterozygosity of UGT1A4 genetic variants *2(P24T) or *3(L48V) in Norwegian patients.
    Shirzadi M; Reimers A; Helde G; Sjursen W; Brodtkorb E
    Seizure; 2017 Feb; 45():169-171. PubMed ID: 28068583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.